{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:47:00Z","timestamp":1791002820766,"version":"4.1.0"},"reference-count":251,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T00:00:00Z","timestamp":1431043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/10\/55\/28467"],"award-info":[{"award-number":["PG\/10\/55\/28467"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/12\/50\/29691"],"award-info":[{"award-number":["PG\/12\/50\/29691"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cgfr.co.uk","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.cytogfr.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T06:00:24Z","timestamp":1431410424000},"page":"673-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":423,"title":["Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets"],"prefix":"10.1016","volume":"26","author":[{"given":"Dipak P.","family":"Ramji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2015.04.003_bib1000","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update a report: from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy","volume":"50","author":"McLaren","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis","volume":"31","author":"Ait-Oufella","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1020","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1025","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"Zadelaar","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1030","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbadis.2015.04.011","article-title":"The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis","volume":"1852","author":"Buckley","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1035","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1040","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1161\/ATVBAHA.114.303424","article-title":"Mechanoresponsive networks controlling vascular inflammation","volume":"34","author":"Bryan","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1045","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1050","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3048","article-title":"Therapeutic targeting of chemokine interactions in atherosclerosis","volume":"9","author":"Koenen","year":"2010","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1060","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/ATVBAHA.113.301655","article-title":"Chemokines in atherosclerosis: proceedings resumed","volume":"34","author":"Zernecke","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1070","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/emmm.201201717","article-title":"Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes","volume":"5","author":"Soehnlein","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1085","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/01.ATV.19.6.1518","article-title":"Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice","volume":"19","author":"Aiello","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1090","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.0000038140.80105.AD","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice","volume":"106","author":"Inoue","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1095","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/ATVBAHA.110.205914","article-title":"Monocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis","volume":"30","author":"Ohman","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1100","doi-asserted-by":"crossref","first-page":"e33497","DOI":"10.1371\/journal.pone.0033497","article-title":"Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1105","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2\u2212\/\u2212 mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"Gu","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1115","doi-asserted-by":"crossref","first-page":"e31508","DOI":"10.1371\/journal.pone.0031508","article-title":"Impact of macrophage inflammatory protein-1\u03b1 deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion","volume":"7","author":"Kennedy","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1120","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/ATVBAHA.112.300857","article-title":"Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation","volume":"33","author":"de Jager","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1125","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/CIRCULATIONAHA.107.708016","article-title":"Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice","volume":"116","author":"Krohn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI66580","article-title":"CXCL5 limits macrophage foam cell formation in atherosclerosis","volume":"123","author":"Rousselle","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1135","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/01.ATV.0000143135.71440.75","article-title":"Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice","volume":"24","author":"Liehn","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1140","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","article-title":"Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells","volume":"113","author":"Heller","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1145","doi-asserted-by":"crossref","first-page":"936109","DOI":"10.4061\/2011\/936109","article-title":"Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans","volume":"2011","author":"Segers","year":"2011","journal-title":"Int J Inflam"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.540583","article-title":"Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis","volume":"114","author":"Aslanian","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cyto.2010.11.016","article-title":"Overexpression of CXCL16 promotes a vulnerable plaque phenotype in apolipoprotein E-knockout mice","volume":"53","author":"Yi","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1160","doi-asserted-by":"crossref","first-page":"17795","DOI":"10.1073\/pnas.0408096101","article-title":"Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root","volume":"101","author":"Teupser","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1165","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1170","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/DDDT.S72394","article-title":"CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions","volume":"8","author":"Akhavanpoor","year":"2014","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1175","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/ATVBAHA.112.301162","article-title":"CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice","volume":"33","author":"Akhtar","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1180","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1160\/TH07-04-0271","article-title":"Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl\/6 and apoE\u2212\/\u2212 mice","volume":"98","author":"Sachais","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1185","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1190","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1161\/01.CIR.0000134704.84454.D2","article-title":"Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"109","author":"Pan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.ATV.0000119356.35748.9e","article-title":"Evidence for a role of macrophage migration inhibitory factor in vascular disease","volume":"24","author":"Chen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1200","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.0000109201.72441.09","article-title":"Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice","volume":"109","author":"Schober","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2005.03.028","article-title":"Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF)","volume":"184","author":"Burger-Kentischer","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.ATV.0000253886.44609.ae","article-title":"Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice","volume":"27","author":"Braunersreuther","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1215","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2005-09-3922","article-title":"Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10","volume":"107","author":"Zernecke","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1220","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI119798","article-title":"Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C\u2013C chemokine receptor 2 knockout mice","volume":"100","author":"Boring","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1225","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1161\/01.ATV.0000143384.69170.2d","article-title":"Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice","volume":"24","author":"Ishibashi","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1230","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.ATV.0000058431.78833.F5","article-title":"Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis","volume":"23","author":"Guo","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1235","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.ATV.0000163181.40896.42","article-title":"Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development","volume":"25","author":"Guo","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/ATVBAHA.109.198812","article-title":"Pharmacological inhibition of C\u2013C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C\u2013C chemokine receptor 2\/apolipoprotein E\u2212\/\u2212 mouse: magnetic resonance imaging assessment","volume":"30","author":"Olzinski","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1245","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","article-title":"Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice","volume":"127","author":"Majmudar","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1250","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/j.atherosclerosis.2007.03.026","article-title":"CC chemokine receptor 5 influences late-stage atherosclerosis","volume":"195","author":"Quinones","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1255","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/ATVBAHA.108.165423","article-title":"A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice","volume":"28","author":"Braunersreuther","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1260","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1265","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.ATV.0000231527.22762.71","article-title":"Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice","volume":"26","author":"Potteaux","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1270","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1160\/TH13-01-0017","article-title":"CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice","volume":"110","author":"Manthey","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1275","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCRESAHA.111.242578","article-title":"Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice","volume":"109","author":"Wan","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1280","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1073\/pnas.0511043103","article-title":"Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice","volume":"103","author":"Trogan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1285","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/CIRCULATIONAHA.110.956730","article-title":"Chemokine receptor 7 knockout attenuates atherosclerotic plaque development","volume":"122","author":"Luchtefeld","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1290","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cvr\/cvs349","article-title":"Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice","volume":"97","author":"Wan","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1295","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2353\/ajpath.2006.040748","article-title":"Up-regulated expression of the CXCR2 ligand KC\/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression","volume":"168","author":"Boisvert","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1300","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/ATVBAHA.107.147827","article-title":"CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice","volume":"28","author":"van Wanrooij","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1305","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/CIRCULATIONAHA.104.520718","article-title":"Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo","volume":"112","author":"Veillard","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1310","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCRESAHA.107.160697","article-title":"Protective role of CXC receptor 4\/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis","volume":"102","author":"Zernecke","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2014.04.021","article-title":"CXCR4 blockade induces atherosclerosis by affecting neutrophil function","volume":"74","author":"Bot","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1320","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1160\/TH11-07-0453","article-title":"The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation","volume":"107","author":"Hamesch","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1325","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/ATVBAHA.113.302878","article-title":"Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice","volume":"34","author":"Noels","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1330","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/CIRCULATIONAHA.106.678474","article-title":"CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall","volume":"116","author":"Galkina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1335","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.113.006840","article-title":"Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue","volume":"129","author":"Li","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1340","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.CIR.0000057548.68243.42","article-title":"Decreased atherosclerotic lesion formation in CX3CR1\/apolipoprotein E double knockout mice","volume":"107","author":"Combadi\u00e8re","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1345","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1172\/JCI15555","article-title":"Decreased atherosclerosis in CX3CR1\u2212\/\u2212 mice reveals a role for fractalkine in atherogenesis","volume":"111","author":"Lesnik","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1350","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.112.300930","article-title":"Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice","volume":"33","author":"Poupel","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1355","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/ATVBAHA.107.158675","article-title":"CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden","volume":"28","author":"Liu","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1365","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","article-title":"Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice","volume":"117","author":"Combadi\u00e8re","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1370","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1194\/jlr.M032482","article-title":"MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K\/Akt posttranslational regulation in HepG2 cells","volume":"54","author":"Huang","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1375","doi-asserted-by":"crossref","first-page":"e97009","DOI":"10.1371\/journal.pone.0097009","article-title":"Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors","volume":"9","author":"Nie","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1380","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.114.302426","article-title":"Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication","volume":"114","author":"D\u00f6ring","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1385","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000145122.58420.CO","article-title":"Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice","volume":"110","author":"Bursill","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/gt.2008.141","article-title":"Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition","volume":"16","author":"Bursill","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1395","doi-asserted-by":"crossref","first-page":"I235","DOI":"10.1161\/CIRCULATIONAHA.104.526129","article-title":"Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice","volume":"112","author":"Ali","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1400","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/CIRCULATIONAHA.107.743872","article-title":"Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2\u2212\/\u2212 mice: evidence for independent chemokine functions in atherogenesis","volume":"117","author":"Saederup","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1405","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1\u03b1 and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1410","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201242687","article-title":"A VLP-based vaccine against interleukin-1\u03b1 protects mice from atherosclerosis","volume":"43","author":"Tissot","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1415","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2011.01.008","article-title":"Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1\u03b1","volume":"405","author":"Kamari","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1420","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1425","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1161\/01.CIR.0000142085.39015.31","article-title":"Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and\/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications","volume":"110","author":"Chi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1430","doi-asserted-by":"crossref","first-page":"e5073","DOI":"10.1371\/journal.pone.0005073","article-title":"Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding","volume":"4","author":"Chamberlain","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1435","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI43713","article-title":"Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice","volume":"122","author":"Alexander","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1440","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2011.12.010","article-title":"Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice","volume":"222","author":"Shemesh","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1445","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","article-title":"Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"216","author":"Bhaskar","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1450","doi-asserted-by":"crossref","first-page":"e002006","DOI":"10.1161\/JAHA.112.002006","article-title":"Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis","volume":"1","author":"Denes","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1455","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1073\/pnas.092324399","article-title":"Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size","volume":"99","author":"Devlin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1460","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","article-title":"Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice","volume":"97","author":"Elhage","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1465","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","article-title":"Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice","volume":"66","author":"Merhi-Soussi","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1470","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.CIR.0000085567.18648.21","article-title":"Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury","volume":"108","author":"Isoda","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1475","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.ATV.0000127025.48140.a3","article-title":"Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice","volume":"24","author":"Isoda","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1480","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.5551\/jat.25668","article-title":"Interleukin-1 receptor antagonist originating from bone marrow derived cells and non-bone marrow-derived cells helps to suppress arterial inflammation and reduce neointimal formation after injury","volume":"21","author":"Isoda","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1485","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000331970405500308","article-title":"Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E-deficient mice","volume":"55","author":"Upadhya","year":"2004","journal-title":"Angiology"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1490","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.112.099044","article-title":"Cytokine therapy with interleukin-2\/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+regulatory T cells and attenuates development and progression of atherosclerosis","volume":"126","author":"Dinh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1495","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/ATVBAHA.113.303097","article-title":"Interleukin-3\/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency","volume":"34","author":"Wang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1500","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1505","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.2353\/ajpath.2007.060857","article-title":"Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice","volume":"171","author":"King","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1510","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI200420479","article-title":"IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis","volume":"114","author":"Binder","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1515","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice","volume":"19","author":"Huber","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1520","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2004.06.018","article-title":"IL-6 and the acute phase response in murine atherosclerosis","volume":"177","author":"Song","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1530","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.atherosclerosis.2007.02.023","article-title":"Atheroprotective role of interleukin-6 in diet- and\/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model","volume":"197","author":"Madan","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1535","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1540","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.abb.2012.09.007","article-title":"Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase \u03b11 via a mitogen-activated protein kinase and c-Jun pathway","volume":"528","author":"Zhang","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1545","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.0000018941.10726.FA","article-title":"Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes","volume":"90","author":"Pinderski","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1550","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1555","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2006.09.032","article-title":"The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice","volume":"193","author":"Eefting","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1560","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jss.2004.03.025","article-title":"Interleukin-10 attenuates the response to vascular injury","volume":"121","author":"Zimmerman","year":"2004","journal-title":"J Surg Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2005.10.029","article-title":"Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10","volume":"188","author":"Liu","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1570","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/sj.gt.3302348","article-title":"Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice","volume":"11","author":"Yoshioka","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1575","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2003.08.032","article-title":"Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice","volume":"172","author":"Namiki","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1580","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1096\/fj.09-148155","article-title":"Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice","volume":"24","author":"Han","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1585","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/01.ATV.0000134378.86443.cd","article-title":"Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice","volume":"24","author":"Potteaux","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1590","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.104.533463","article-title":"Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis","volume":"112","author":"Hauer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1595","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.ATV.19.3.734","article-title":"The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1600","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/emmm.201201374","article-title":"Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype","volume":"4","author":"Cardilo-Reis","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1605","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2010.11.037","article-title":"IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice","volume":"29","author":"van Es","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1610","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2005.11.050","article-title":"Autocrine role of vascular IL-15 in intimal thickening","volume":"339","author":"Cercek","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1615","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1620","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1625","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","article-title":"The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment","volume":"110","author":"Butcher","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1630","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1635","doi-asserted-by":"crossref","first-page":"247503","DOI":"10.1155\/2014\/247503","article-title":"Interleukin-17A exacerbates ferric chloride-induced arterial thrombosis in rat carotid artery","volume":"2014","author":"Maione","year":"2014","journal-title":"Int J Inflam"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1640","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.07.152","article-title":"Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice","volume":"388","author":"van Es","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1645","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/ATVBAHA.111.227629","article-title":"Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice","volume":"31","author":"Madhur","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1650","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1655","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1660","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1665","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.4049\/jimmunol.1001879","article-title":"IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice","volume":"185","author":"Chen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1670","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2008.12.032","article-title":"Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet","volume":"47","author":"Pejnovic","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1675","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/01.ATV.0000153516.02782.65","article-title":"IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells","volume":"25","author":"Tenger","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1680","article-title":"Interleukin-18-induced atherosclerosis involves CD36 and NF-\u03baB crosstalk in Apo E\u2212\/\u2212 mice","author":"Bhat","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1685","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","article-title":"Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice","volume":"59","author":"Elhage","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1690","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1161\/hh0202.105292","article-title":"Interleukin-18 enhances atherosclerosis in apolipoprotein E(\u2212\/\u2212) mice through release of interferon-gamma","volume":"90","author":"Whitman","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1695","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1700","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/ATVBAHA.113.301521","article-title":"Attenuation of experimental atherosclerosis by interleukin-19","volume":"33","author":"Ellison","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1705","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ajpath.2014.04.001","article-title":"IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation","volume":"184","author":"Ellison","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1710","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/01.ATV.0000232502.88144.6f","article-title":"IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Chen","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1715","doi-asserted-by":"crossref","first-page":"e0117255","DOI":"10.1371\/journal.pone.0117255","article-title":"IL-25 Inhibits atherosclerosis development in apolipoprotein E deficient mice","volume":"10","author":"Mantani","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1720","doi-asserted-by":"crossref","first-page":"H420","DOI":"10.1152\/ajpheart.00198.2013","article-title":"Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice","volume":"305","author":"Hirase","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1725","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCRESAHA.112.277525","article-title":"Interleukin-27 receptor limits atherosclerosis in Ldlr\u2212\/\u2212 mice","volume":"111","author":"Koltsova","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1730","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1735","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.1000520","article-title":"IL-33 reduces macrophage foam cell formation","volume":"185","author":"Mclaren","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1740","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20100370","article-title":"Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis","volume":"208","author":"de Jager","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1745","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.carpath.2012.02.003","article-title":"Increased expression of the TGF-beta superfamily cytokine MIC-1\/GDF15 protects ApoE(\u2212\/\u2212) mice from the development of atherosclerosis","volume":"21","author":"Johnen","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1750","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-783X-18-19","article-title":"GDF-15 protects from macrophage accumulation in a mouse model of advanced atherosclerosis","volume":"18","author":"Preusch","year":"2013","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1755","doi-asserted-by":"crossref","first-page":"e002550","DOI":"10.1161\/JAHA.112.002550","article-title":"Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury","volume":"1","author":"Bonaterra","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1760","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/CIRCULATIONAHA.106.665570","article-title":"Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice","volume":"115","author":"Haghighat","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1765","first-page":"1979","article-title":"Effects of G-CSF on serum cholesterol and development of atherosclerotic plaque in apolipoprotein E-deficient mice","volume":"7","author":"Sinha","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1770","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.yjmcc.2011.12.016","article-title":"Role of regulatory T cells in atheroprotective effects of granulocyte colony-stimulating factor","volume":"52","author":"Uchiyama","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1775","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/CIRCRESAHA.116.304794","article-title":"Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling","volume":"116","author":"Subramanian","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1780","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.ATV.0000238357.60338.90","article-title":"GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice","volume":"26","author":"Ditiatkovski","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1785","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/01.ATV.0000254673.55431.e6","article-title":"Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions","volume":"27","author":"Shaposhnik","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1790","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejim.2003.08.010","article-title":"Low-dose interferon-alpha accelerates atherosclerosis in an LDL receptor-deficient mouse model","volume":"14","author":"Levy","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1795","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions","volume":"12","author":"Goossens","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1800","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.atherosclerosis.2007.03.019","article-title":"Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice","volume":"197","author":"Zhang","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1805","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1810","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1815","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/10799900260100141","article-title":"IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E\u2212\/\u2212 mice","volume":"22","author":"Whitman","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1820","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","article-title":"Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"Buono","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1825","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5551\/jat.11.79","article-title":"Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient mice","volume":"11","author":"Niwa","year":"2004","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1830","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","article-title":"Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice","volume":"101","author":"Koga","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1835","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1291\/hypres.30.259","article-title":"Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice","volume":"30","author":"Koga","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1840","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1073\/pnas.92.18.8264","article-title":"Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E","volume":"92","author":"Smith","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1845","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI119891","article-title":"Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice","volume":"101","author":"Rajavashisth","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1850","first-page":"1687","article-title":"Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice","volume":"150","author":"Qiao","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1855","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.ATV.18.4.631","article-title":"Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein E","volume":"18","author":"de Villiers","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1860","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/hh2201.099415","article-title":"Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1865","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1182\/blood-2003-05-1729","article-title":"Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice","volume":"102","author":"Gojova","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1870","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1172\/JCI18607","article-title":"Disruption of TGF-beta signaling in T cells accelerates atherosclerosis","volume":"112","author":"Robertson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1875","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/ATVBAHA.109.186593","article-title":"TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice","volume":"29","author":"Frutkin","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1880","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/ATVBAHA.107.150300","article-title":"Transforming growth factor activity is a key determinant for the effect of estradiol on fatty streak deposit in hypercholesterolemic mice","volume":"27","author":"Gourdy","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1885","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/eurheartj\/ehs106","article-title":"Abrogated transforming growth factor beta receptor II (TGF\u03b2RII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis","volume":"34","author":"Lievens","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1890","doi-asserted-by":"crossref","first-page":"e40990","DOI":"10.1371\/journal.pone.0040990","article-title":"Overexpression of TGF-\u00df1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice","volume":"7","author":"Reifenberg","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1895","doi-asserted-by":"crossref","first-page":"e81444","DOI":"10.1371\/journal.pone.0081444","article-title":"T cell-specific overexpression of TGF\u00df1 fails to influence atherosclerosis in ApoE-deficient mice","volume":"8","author":"Reifenberg","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1900","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1194\/jlr.P040139","article-title":"Prevention of TGF\u03b2 induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr\u2212\/\u2212 mice","volume":"54","author":"Tang","year":"2013","journal-title":"J Lipid Res"},{"issue":"196","key":"10.1016\/j.cytogfr.2015.04.003_bib1905","doi-asserted-by":"crossref","first-page":"ra00","DOI":"10.1126\/scitranslmed.3006133","article-title":"Transforming growth factor-\u03b2 signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway","volume":"5","author":"Gister\u00e5","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1910","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice","volume":"24","author":"Br\u00e5n\u00e9n","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1915","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","article-title":"Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice","volume":"180","author":"Ohta","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1920","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cardiores.2005.01.001","article-title":"Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice","volume":"66","author":"Boesten","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1925","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.ATV.0000261548.49790.63","article-title":"Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis","volume":"27","author":"Zhang","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1930","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2003.10.004","article-title":"Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus","volume":"172","author":"Canault","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1935","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/path.2305","article-title":"Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha","volume":"214","author":"Canault","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1940","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cvr\/cvn193","article-title":"p55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice","volume":"80","author":"Xanthoulea","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1945","doi-asserted-by":"crossref","first-page":"e6113","DOI":"10.1371\/journal.pone.0006113","article-title":"Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice","volume":"4","author":"Xanthoulea","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1950","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2008.11.166","article-title":"Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice","volume":"96","author":"Xiao","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1955","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jcmm.12221","article-title":"Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice","volume":"18","author":"Sastre","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1960","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.106.643841","article-title":"Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice","volume":"114","author":"Secchiero","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1965","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2011.01.010","article-title":"TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice","volume":"215","author":"Watt","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1970","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00125-011-2308-0","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe \u2212\/\u2212 mice","volume":"54","author":"Di Bartolo","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1975","doi-asserted-by":"crossref","first-page":"e74211","DOI":"10.1371\/journal.pone.0074211","article-title":"TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL","volume":"8","author":"Di Bartolo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1980","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1985","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1160\/TH11-05-0320","article-title":"Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation","volume":"106","author":"Wolfs","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1990","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib1995","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/ATVBAHA.112.300173","article-title":"Phenotypic polarization of macrophages in atherosclerosis","volume":"33","author":"Leitinger","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2000","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/138161211795049831","article-title":"Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease","volume":"17","author":"Tsimikas","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1024656613633","article-title":"Tumor necrosis factor-alpha in low doses preactivates and activates macrophages by increasing their ability to produce reactive oxygen species and oxidize low-density lipoproteins: protective effect of antioxidants","volume":"135","author":"Bilenko","year":"2003","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-5793(94)80113-4","article-title":"Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells","volume":"338","author":"Maziere","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2015","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.ATV.17.10.1954","article-title":"Cytokine modulation of LDL oxidation by activated human monocytes","volume":"17","author":"Folcik","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/niox.2000.0293","article-title":"Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation","volume":"4","author":"Niu","year":"2000","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2025","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1172\/JCI117211","article-title":"Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway","volume":"93","author":"Christen","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCRESAHA.108.192880","article-title":"Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake","volume":"104","author":"Choi","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2035","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.ATV.0000124102.11472.36","article-title":"CXCL16\/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions","volume":"24","author":"Wuttge","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2040","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.4049\/jimmunol.1000993","article-title":"ERK Is Integral to the IFN-gamma-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2045","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/01.ATV.20.6.1565","article-title":"Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells","volume":"20","author":"Panousis","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-2275(20)32076-9","article-title":"Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma","volume":"41","author":"Panousis","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2055","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.4049\/jimmunol.0903782","article-title":"The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro","volume":"184","author":"Mclaren","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2060","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0022-2275(20)31648-5","article-title":"TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma","volume":"42","author":"Panousis","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2065","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbadis.2012.06.002","article-title":"TGF-beta inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: a dominant role for Smad-2","volume":"1822","author":"Michael","year":"2012","journal-title":"Biochim Biophys Acta\u2014Mol Basis Dis"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cytogfr.2006.09.002","article-title":"The role of transforming growth factor-beta in atherosclerosis","volume":"17","author":"Singh","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cyto.2013.05.016","article-title":"Differential regulation of macropinocytosis in macrophages by cytokines: Implications for foam cell formation and atherosclerosis","volume":"64","author":"Michael","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11883-012-0239-y","article-title":"Liver X receptors, atherosclerosis and inflammation","volume":"14","author":"Michael","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2085","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.4049\/jimmunol.1201393","article-title":"Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-\u03b3-induced inflammatory responses and LXR-dependent gene expression","volume":"190","author":"Pascual-Garc\u00eda","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2090","doi-asserted-by":"crossref","first-page":"16390","DOI":"10.1074\/jbc.M000953200","article-title":"The acute phase response is associated with retinoid X receptor repression in rodent liver","volume":"275","author":"Beigneux","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2095","doi-asserted-by":"crossref","first-page":"30926","DOI":"10.1074\/jbc.M111.264325","article-title":"Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response","volume":"286","author":"Frisdal","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2100","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.4049\/jimmunol.178.12.8117","article-title":"TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms","volume":"178","author":"McPhillips","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2105","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCRESAHA.108.181040","article-title":"Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2","volume":"104","author":"Bae","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-pathol-020712-163936","article-title":"The influence of innate and adaptive immune responses on atherosclerosis","volume":"9","author":"Witztum","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2130","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCRESAHA.114.302761","article-title":"Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis","volume":"114","author":"Ait-Oufella","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2135","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/cvr\/cvu171","article-title":"Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis","volume":"103","author":"Johnson","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MOL.0000000000000113","article-title":"Smooth muscle cell phenotypic switch: implications for foam cell formation","volume":"25","author":"Chaabane","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2145","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/01.ATV.0000217957.93135.c2","article-title":"Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines","volume":"26","author":"Ruan","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MOL.0b013e328357a379","article-title":"Macrophage proliferation and apoptosis in atherosclerosis","volume":"23","author":"Andr\u00e9s","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2012.06600.x","article-title":"Cellular and molecular players in the atherosclerotic plaque progression","volume":"1262","author":"Businaro","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2160","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2165","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.ATV.11.5.1223","article-title":"Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells","volume":"11","author":"Amento","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2170","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2174\/1568026611208011132","article-title":"Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases","volume":"12","author":"Siasos","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2175","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/cvr\/cvq278","article-title":"TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells","volume":"89","author":"Mu\u00f1oz-Garc\u00eda","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2185","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2174\/138161212799504731","article-title":"Inflammation-induced thrombosis: mechanisms, disease associations and management","volume":"18","author":"Aksu","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2190","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1160\/TH08-04-0269","article-title":"Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins","volume":"100","author":"Kruithof","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1160\/TH13-06-0517","article-title":"Human tissue-type plasminogen activator","volume":"112","author":"Kruithof","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2200","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.thromres.2004.06.028","article-title":"The impact of the inflammatory response on coagulation","volume":"114","author":"Esmon","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jcb.22976","article-title":"Molecular mechanisms underlying the inhibition of IFN-gamma-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs","volume":"112","author":"Li","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","article-title":"Anti-inflammatory therapies for atherosclerosis","volume":"12","author":"B\u00e4ck","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ahj.2013.03.018","article-title":"Rationale and design of the cardiovascular inflammation reduction trial: a test of the inflammatory hypothesis of atherothrombosis","volume":"166","author":"Everett","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2225","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1\u03b2 inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2230","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.amjcard.2010.11.005","article-title":"Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region","volume":"107","author":"Gilbert","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2235","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MOL.0000000000000108","article-title":"Noncoding RNAs in vascular inflammation and atherosclerosis: recent advances toward therapeutic applications","volume":"25","author":"Cochain","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2240","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.112.000736","article-title":"The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis","volume":"127","author":"Wei","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2245","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/ATVBAHA.113.302701","article-title":"MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice","volume":"34","author":"Du","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2015.04.003_bib2250","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/emmm.201202318","article-title":"MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways","volume":"5","author":"Cheng","year":"2013","journal-title":"EMBO Mol Med"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610115000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610115000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T22:36:01Z","timestamp":1651962961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610115000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":251,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1359610115000325"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2015.04.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}